Skip to content

NLKKBZCWASPCKI-UHFFFAOYSA-N

C43H56N6O6Si — CID 58117336

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl 2-[5-[[1-[(4-methylphenyl)methyl]pyrazole-4-carbonyl]amino]-2-oxo-1-(2-trimethylsilylethoxymethyl)-3-pyridinyl]-5-(2-piperidin-1-ylethoxy)indole-1-carboxylate
SMILESCc1ccc(Cn2cc(C(=O)Nc3cc(-c4cc5cc(OCCN6CCCCC6)ccc5n4C(=O)OC(C)(C)C)c(=O)n(COCC[Si](C)(C)C)c3)cn2)cc1
InChIInChI=1S/C43H56N6O6Si/c1-31-11-13-32(14-12-31)27-48-28-34(26-44-48)40(50)45-35-25-37(41(51)47(29-35)30-53-21-22-56(5,6)7)39-24-33-23-36(54-20-19-46-17-9-8-10-18-46)15-16-38(33)49(39)42(52)55-43(2,3)4/h11-16,23-26,28-29H,8-10,17-22,27,30H2,1-7H3,(H,45,50)
InChIKeyNLKKBZCWASPCKI-UHFFFAOYSA-N
MW781.04 g/mol
LogP8.24
Rot. Bonds14

About NLKKBZCWASPCKI-UHFFFAOYSA-N

NLKKBZCWASPCKI-UHFFFAOYSA-N (PubChem CID 58117336) has the molecular formula C43H56N6O6Si and a molecular weight of 781.04 g/mol. Its IUPAC name is tert-butyl 2-[5-[[1-[(4-methylphenyl)methyl]pyrazole-4-carbonyl]amino]-2-oxo-1-(2-trimethylsilylethoxymethyl)-3-pyridinyl]-5-(2-piperidin-1-ylethoxy)indole-1-carboxylate.

Molecular Properties

Compound NameNLKKBZCWASPCKI-UHFFFAOYSA-N
PubChem CID58117336
Molecular FormulaC43H56N6O6Si
Molecular Weight781.04 g/mol
Exact Mass780.40
IUPAC Nametert-butyl 2-[5-[[1-[(4-methylphenyl)methyl]pyrazole-4-carbonyl]amino]-2-oxo-1-(2-trimethylsilylethoxymethyl)-3-pyridinyl]-5-(2-piperidin-1-ylethoxy)indole-1-carboxylate
SMILESCc1ccc(Cn2cc(C(=O)Nc3cc(-c4cc5cc(OCCN6CCCCC6)ccc5n4C(=O)OC(C)(C)C)c(=O)n(COCC[Si](C)(C)C)c3)cn2)cc1
InChIInChI=1S/C43H56N6O6Si/c1-31-11-13-32(14-12-31)27-48-28-34(26-44-48)40(50)45-35-25-37(41(51)47(29-35)30-53-21-22-56(5,6)7)39-24-33-23-36(54-20-19-46-17-9-8-10-18-46)15-16-38(33)49(39)42(52)55-43(2,3)4/h11-16,23-26,28-29H,8-10,17-22,27,30H2,1-7H3,(H,45,50)
InChIKeyNLKKBZCWASPCKI-UHFFFAOYSA-N
XLogP8.24
TPSA121.85 Ų
H-Bond Donors1
H-Bond Acceptors11
Rotatable Bonds14
Heavy Atoms56
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500781.04
LogP ≤ 58.24
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze NLKKBZCWASPCKI-UHFFFAOYSA-N with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of NLKKBZCWASPCKI-UHFFFAOYSA-N?
The IUPAC name of NLKKBZCWASPCKI-UHFFFAOYSA-N (CID 58117336) is tert-butyl 2-[5-[[1-[(4-methylphenyl)methyl]pyrazole-4-carbonyl]amino]-2-oxo-1-(2-trimethylsilylethoxymethyl)-3-pyridinyl]-5-(2-piperidin-1-ylethoxy)indole-1-carboxylate.
What is the SMILES notation for NLKKBZCWASPCKI-UHFFFAOYSA-N?
The canonical SMILES for NLKKBZCWASPCKI-UHFFFAOYSA-N is Cc1ccc(Cn2cc(C(=O)Nc3cc(-c4cc5cc(OCCN6CCCCC6)ccc5n4C(=O)OC(C)(C)C)c(=O)n(COCC[Si](C)(C)C)c3)cn2)cc1.
What is the InChIKey of NLKKBZCWASPCKI-UHFFFAOYSA-N?
The InChIKey is NLKKBZCWASPCKI-UHFFFAOYSA-N. The full InChI is InChI=1S/C43H56N6O6Si/c1-31-11-13-32(14-12-31)27-48-28-34(26-44-48)40(50)45-35-25-37(41(51)47(29-35)30-53-21-22-56(5,6)7)39-24-33-23-36(54-20-19-46-17-9-8-10-18-46)15-16-38(33)49(39)42(52)55-43(2,3)4/h11-16,23-26,28-29H,8-10,17-22,27,30H2,1-7H3,(H,45,50).
What are the key properties of NLKKBZCWASPCKI-UHFFFAOYSA-N?
NLKKBZCWASPCKI-UHFFFAOYSA-N has a molecular weight of 781.04 g/mol, XLogP of 8.24, 14 rotatable bonds, 1 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for NLKKBZCWASPCKI-UHFFFAOYSA-N is sourced from PubChem (CID 58117336), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.